StonvexLoading…
StonvexStonvexStonvexCore line items from TMUS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $23.11B | $88.31B | $63.98B | $42.02B |
Operating Income | $4.50B | $18.28B | $14.54B | $10.01B |
Net Income | $2.50B | $10.99B | $8.89B | $6.17B |
EPS (Diluted) | $2.27 | $9.72 | $7.82 | $5.42 |
Total Assets | $214.67B | $219.24B | $217.18B | $212.64B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $3.52B | $5.60B | $3.31B | $10.26B |
Free Cash Flow OCF − CapEx | $4.60B | $18.00B | $13.81B | $8.99B |
Shares Outstanding | 1.09B | 1.11B | 1.12B | 1.13B |